Human natural killer T cells acquire a memory-activated phenotype before birth

Blood

Volumn 95, Issue 7, 2000, Pages 2440-2442

  Van Der Vliet, Hans J J ^a   Nishi, Nobusuke ^a   De Gruijl, Tanja D ^a   Von Blomberg, B Mary E ^a   Van Den Eertwegh, Alfons J M ^a   Pinedo, Herbert M ^a   Giaccone, Giuseppe ^a   Scheper, Rik J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CD69 ANTIGEN; HOMING RECEPTOR; INTERLEUKIN 2 RECEPTOR; L SELECTIN; PADGEM PROTEIN;

ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FETUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOLOGICAL MEMORY; INFANT; MONONUCLEAR CELL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR REJECTION; UMBILICAL CORD BLOOD;

EID: 0034176822     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.7.2440     Document Type: Article

References (21)

1. - T cells in mice and humans. J Exp Med. 1994:180:1097.
2. - T cells. J Exp Med. 1994:180:1171.
3. -CD8 α/β T cells demonstrates preferential use of several Vβ genes and an invariant α chain. J Exp Med. 1993; 178:1.
4. Cui J, Shin T, Kawano T, et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science. 1997;278:1623.
5. Wilson SB, Kent SC, Patton KT, et al. Extreme Th1 bias of invariant Vα24JαQ T cells in type I diabetes. Nature. 1998;391:177.
6. + NK T cells associated with disease development in autoimmune-prone mice. J Immunol. 1996;156:4035.
7. Sumida T, Sakamoto A, Murata H, et al. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis. J Exp Med. 1995;182:1163.
8. Nakagawa R, Motoki K, Ueno H, et al. Treatment of hepatic metastasis of the colon26 adenocarcinoma with an α-galactosylceramide, KRN7000. Cancer Res. 1998;58:1202.
9. Prussin C, Foster B. TCR Vα24 and Vβ11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation. J Immunol. 1997;159:5862.
10. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA, Herzenberg LA. CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest. 1995;95:2061.
11. Dutton RW, Bradley LM, Swain SL. T cell memory. Annu Rev Immunol. 1998;16:201.
12. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Buck D, Terstappen LWMM. Control of lymphocyte recirculation in man. 1. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition. J Immunol. 1993;150:1105.
13. dim natural killer cell subsets. J Immunol. 1998;161:400.
14. Kawano T, Tanaka Y, Shimizu E, et al. A novel recognition motif of human NKT antigen receptor for a glycolipid ligand. Int Immunol. 1999;11:881.
15. Porcelli SA, Modlin RL. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol. 1999; 17:297.
16. Kawano T, Cui J, Koezuka Y, et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science. 1997; 278:1626.
17. Brossay L, Chioda M, Burdin N, et al. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med. 1998;188:1521.
18. Spada FM, Koezuka Y, Porcelli SA. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med. 1998;188:1529.
19. Canchis PW, Bhan AK, Landau SB, Yang L, Balk SP, Blumberg RS. Tissue distribution of the non-polymorphic major histocompatibility complex class I-like molecule CD1d. Immunology. 1993; 80:561.
20. Jenkinson HJ, Wainwright SD, Simpson KL, Perry ACF, Fotiadou P, Holmes CH. Expression of CD1d mRNA transcripts in human choriocarcinoma cell lines and placentally derived trophoblast cells. Immunology. 1999;96:649.
21. Sonoda K-H, Exley M, Snapper S, Balk SP, Stein-Streilein J. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J Exp Med. 1999;190:1215.